US Patent Issued to NADIANBIO on July 29 for "Composition comprising naphthoquinone-based compound as active ingredient, for preventing or ameliorating fatigue, cachexia, pain, cognitive decline and hematopoietic stem cell reduction which are side effects related to anticancer drug treatment" (South Korean Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,170, issued on July 29, was assigned to NADIANBIO Ltd. (Iksan-si, South Korea).

"Composition comprising naphthoquinone-based compound as active ingredient, for preventing or ameliorating fatigue, cachexia, pain, cognitive decline and hematopoietic stem cell reduction which are side effects related to anticancer drug treatment" was invented by Hong Seob So (Iksan-si, South Korea), Hyung-Jin Kim (Iksan-si, South Korea), Gi-Su Oh (Iksan-si, South Korea), Seunghoon Lee (Iksan-si, South Korea) and Dipendra Khadka (Iksan-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition comprising a naphthoquinone-based compound as an active ing...